New study examines immunotherapy outcomes in american indian cancer patients

NCT ID NCT05863052

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviews medical records of 72 American Indian patients treated with immunotherapy for cancers like lung cancer, melanoma, and kidney cancer. Researchers compare their outcomes—such as how long the cancer is controlled and side effects—to those of White patients. The goal is to identify any healthcare disparities and guide future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
immunotherapy
What this could lead to
If successful, this could reveal differences in how well immunotherapy works for American Indian patients and point to ways to improve their cancer care.
What could go wrong
This is a small, retrospective study that only looks at past data, so it cannot prove cause and effect. Results may not apply to all American Indian populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arizona Cancer Center at the Unvieristy of Arizona

    Tucson, Arizona, 85719, United States

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Huntsman Cancer Institute at the University of Utah

    Salt Lake City, Utah, 84112, United States

  • Monument Health Cancer Care Institute

    Rapid City, South Dakota, 57701, United States

  • Stephenson Cancer Center

    Oklahoma City, Oklahoma, 73117, United States

  • University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico, 87102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.